Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest announcement is out from Conduit Pharmaceuticals ( (CDT) ).
Conduit Pharmaceuticals Inc. has appointed Simon Fry as a director, leveraging his extensive 35-year experience in investment banking, with his role effective post the 2024 annual stockholders meeting. Additionally, the company has amended its employment agreement with James Bligh, maintaining his position as Interim CFO with a revised compensation package. An amendment to the Bylaws also modifies quorum requirements for stockholder meetings, reducing the threshold to one-third of voting power, effective after the 2024 stockholders meeting.
For a thorough assessment of CDT stock, go to TipRanks’ Stock Analysis page.
